Clinical Study of the Treatment of Chronic Empyema with Open Window Thoracostomy: 10 Years Experience.
- Author:
Young Kyu KIM
1
;
Yeong Dae KIM
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Pusan National University College of Medicine. domini@pnu.edu
- Publication Type:Original Article
- Keywords:
Empyema;
Drainage
- MeSH:
Aspergillosis;
Busan;
Drainage;
Empyema*;
Empyema, Tuberculous;
Female;
Fistula;
Hernia, Abdominal;
Humans;
Male;
Myocutaneous Flap;
Necrosis;
Pleura;
Rectus Abdominis;
Respiratory Function Tests;
Retrospective Studies;
Ribs;
Shock, Septic;
Skin;
Thoracostomy*
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2007;40(11):765-769
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The curative treatment of choice for empyema is decortication of the pleura. The risks of this treatment however are increased for the patient with reduced pulmonary function, complicated calcification or septic shock. In the past, open window thoracostomy was a final stage treatment for chronic empyema. Relatively safe treatment of empyema could be achieved in difficult cases with a closure of the open window after open drainage and use of a myocutaneous flap (one stage or staged). MATERIAL AND METHOD: A retrospective study of the cause, progression and final outcome of empyema patients who received open window thoracostomy was performed. 21 patients were followed from 1995 to 2004 in the department of Thoracic and Cardiovascular Surgery in the College of Medicine, Pusan National University. RESULT: The average age of the patients was 57.5+/-15.5 years (range 25~78 years), of whom 16 (76.2%) were men and five (23.8%) were women. Pulmonary function test results showed an average FEV1 of 1.58+/-0.49 L. The type of empyema was tuberculous empyema in 13 cases (61.9%), aspergillosis in three cases (14.3%), parapneumonic empyema in three cases (14.3%) and post-resectional empyema in two cases (10%). Bronchopulmonary fistula was seen in 14 cases. Eight cases were complicated by severe calcification of the pleura. For the four cases of bronchopulmonary fistula, the patients' serratus anterior muscle was covered in their first operation. The average number of ribs resected was 4+/-1. Closure of the open window thoracostomy was performed in 12 cases. The average time to closure after open drainage was 10.22+/-3.11 months and the average defect of the empyemal cavity before the final operation was 330+/-110 cc. Among the 12 cases, there were two cases of spontaneous closure. In two cases closure was only achieved by using the reserved skin fold during the first surgery. Of the remaining eight cases, in seven we used the myocutaneous flap (four cases of lattisimus dorsi muscle and three cases of pectoralis major muscle), and in one case we used soft tissue. As regards complications of the closure, tissue necrosis occurred in one case, which led to failed closure, and there was one case of abdominal hernia in the rectus abdominis muscle flap. One patient died within 30 days of the surgery and one patient died of metastatic cancer. CONCLUSION: A staged operation with a final closure using open window thoracostomy, which consists of open drainage, transposition of the muscle and a myocutaneous flap, can be a safe and effective option for the chronic empyema patient who is difficult to cure with traditional surgical methods.
